Centrica: Leading bank flags weaker 2026 outlook and pauses buyback

Centrica reported FY adjusted EPS of 11.2p (in line with consensus and UBS’s 11.3p), net cash of £1.49bn (above UBS’s £1.24bn) and £0.5bn of impairments on gas production and nuclear assets; British Gas Services & Solutions delivered £114m of operating profit versus UBS’s £85m estimate while Centrica Energy missed at £150m versus UBS’s £203m. Management issued 2026 guidance that was weaker than UBS forecasts (retail & optimisation EBITDA centre £900m vs UBS £977m; Optimisation guided £100m below centre implying c.£200m EBIT for Centrica Energy vs UBS £267m) and flagged higher net interest (£100m guided vs UBS £57m), rising aged retail receivables (£1.95bn to £2.48bn) and higher provisions (£0.8bn to £1.04bn); the company paused its buyback and shares fell about 6% intraday to c.185p. UBS still retains a buy rating but lowered sentiment due to the softer 2026 outlook, buyback pause and working-capital pressure, making the update a negative catalyst for the stock.

Analysis

Market structure: Centrica’s pause of the buyback, £0.5bn impairments and rising aged receivables (to £2.48bn) reprice UK retail-energy risk and benefit counter-parties with lower retail exposure (SSE.L, NG.L) and pure-play optimisation/trading peers when commodity curves recover. Pricing power for domestic supply is constrained by regulated caps and rising working capital; expect continued margin compression in retail with optimisation/Energy trading volatility tied to gas curves and storage economics (Rough breakeven in 2026). Cross-asset: expect wider credit spreads for UK energy retail credits, higher implied equity vol for CNA.L (near-term) and modest GBP downside if systemic retail stress triggers policy talk; UK sovereign unaffected but corporate bond yields in sector could rerate +50–150bps on stress.

Risk assessment: tail risks include regulatory intervention (re-setting price caps or forced consumer credit relief), a severe cold shock that spikes bad-debt and wholesale prices, or nuclear life-extension denial that removes the 2030 EBITDA uplift — each could knock 20–40% off current equity value. Near-term (days–weeks) risk is sentiment-led downside (further 10–20% falls after buyback pause); medium (3–12 months) is receivables crystallisation and higher net interest (guided £100m vs UBS £57m); long-term (2–5 years) depends on successful optimisation and A/GCR life extensions. Catalysts: regulatory statements (30–90 days), Q1 trading update, commodity curve shifts, and any reinstatement of capital returns.

Trade implications: direct: tactical short CNA.L (LSE:CNA) sized 1–2% portfolio via a 3–6 month put spread (e.g., buy 190p put, sell 150p put) to cap premium; target 140–160p, stop at 220p. Pair trade: long SSE.L or NG.L (1–2%) vs short CNA.L (1–2%) to capture relative earnings stability over 6–12 months. Options: sell short-dated covered calls only if long CNA; buy 3–6 month puts on CNA to hedge existing exposure. Rotate 2–4% portfolio from retail supply names into regulated networks/renewables (NG.L, SSE.L) given clearer cashflow visibility.

Contrarian angles: consensus treats receivables deterioration as structural; but net cash £1.49bn and Rough breakeven reduce insolvency risk — a 20–30% overshoot in downside may be overdone if commodity curves recover. UBS’s 200p PT vs market 185p implies thin upside; if Centrica reintroduces buybacks or executes disposals, re-rate could be 25–40% upside. Historical parallels: post-commodity-cycle impairments (2014–16) saw multi-year recovery once curves normalized. Unintended consequence: aggressive provisioning may constrain CAPEX, slowing decarbonisation projects and inviting regulatory scrutiny, which could extend valuation discount.

Key Decisions for Investors

• Establish a tactical 1–2% portfolio short in Centrica (LSE:CNA) via a 3–6 month put spread: buy 190p put / sell 150p put (net debit). Target exit 140–160p (30–45% downside) or if realized gain >50%; hard stop-loss if CNA >220p intraday.
• Execute a 1–2% pair trade: long SSE.L (or NG.L) equal-weight vs short CNA.L to capture relative stability; hold 6–12 months and rebalance if Centrica aged receivables exceed £2.6bn or provisions >£1.2bn.
• Buy 3–6 month ATM puts on CNA to hedge any existing UK energy retail exposure sized to offset 75% of that exposure; reduce strikes/exposure if net interest expense guidance stays near £100m or if commodity curves materially improve.
• Reallocate 2–4% of portfolio from UK retail-energy names into regulated/renewable utilities (NG.L, SSE.L) and fixed-rate investment-grade utility bonds; increase cash/short-duration bonds if credit spreads widen >75bps in the sector.
• Monitor three binary catalysts in next 30–90 days before scaling: (1) Ofgem/regulatory comment on price caps, (2) Q1 trading update/receivables trend, (3) any announcement on nuclear life-extension or asset disposals. If buyback resumes or net receivables fall >£200m sequentially, close short positions.